Establishment of Peritoneal and Hepatic Metastasis Mouse Xenograft Models Using Gastric Cancer Cell Lines

被引:21
作者
Miwa, Takashi [1 ]
Kanda, Mitsuro [1 ]
Umeda, Shinichi [1 ]
Tanaka, Haruyoshi [1 ]
Shimizu, Dai [1 ]
Tanaka, Chie [1 ]
Kobayashi, Daisuke [1 ]
Hayashi, Masamichi [1 ]
Yamada, Suguru [1 ]
Nakayama, Goro [1 ]
Koike, Masahiko [1 ]
Kodera, Yasuhiro [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi, Japan
来源
IN VIVO | 2019年 / 33卷 / 06期
关键词
Gastric cancer; peritoneal metastasis; hepatic metastasis; xenograft; LIVER; GENE; NANOPARTICLES; CHEMOTHERAPY; TRASTUZUMAB; EXPRESSION; THERAPY; NUDE;
D O I
10.21873/invivo.11669
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: Establishment of mouse xenograft models is necessary for oncological research and depends on the characteristics of the cell lines and the immune system of the host. In this study, we describe the development of mouse xenograft models using human gastric cancer (GC) cell lines. Materials and Methods: MKN1 stably-expressing luciferase (MKN1-Luc), N87, KATO III, MKN45 stably-expressing luciferase (MKN45-Luc), NUGC4, and OCUM-1 human GC cell lines were injected intraperitoneally into mice to establish peritoneal metastasis models. MKN45-Luc were injected into subcutaneously implanted spleen, and MKN1-Luc and MKN45-Luc were injected directly into the portal veins of mice for the establishment of hepatic metastasis models. Results: Peritoneal metastasis was formed after implantation of MKN1-Luc, N87, KATO III, MKN45-Luc, and NUGC4 in nude mice, but not formed in OCUM-1 even in NOD/SCID mice. After intrasplenic injection of MKN45-Luc, we found no hepatic metastasis formation. We identified hepatic metastasis formation after direct injection of MKN45-Luc and MKN1-Luc into the portal veins of NOD/SCID mice. Conclusion: Peritoneal and hepatic metastasis mouse xenograft models were successfully established using several human GC cell lines.
引用
收藏
页码:1785 / 1792
页数:8
相关论文
共 36 条
  • [1] [Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
  • [2] Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
    Bang, Yung-Jue
    Kim, Young-Woo
    Yang, Han-Kwang
    Chung, Hyun Cheol
    Park, Young-Kyu
    Lee, Kyung Hee
    Lee, Keun-Wook
    Kim, Yong Ho
    Noh, Sang-Ik
    Cho, Jae Yong
    Mok, Young Jae
    Kim, Yeul Hong
    Ji, Jiafu
    Yeh, Ta-Sen
    Button, Peter
    Sirzen, Florin
    Noh, Sung Hoon
    [J]. LANCET, 2012, 379 (9813) : 315 - 321
  • [3] INDUCTION OF SARCOMAS IN ATHYMIC MICE
    BEATTIE, GM
    KNOWLES, AF
    JENSEN, FC
    BAIRD, SM
    KAPLAN, NO
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (09): : 3033 - 3036
  • [4] Endosomal proteolysis and MHC class II function
    Chapman, HA
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (01) : 93 - 102
  • [5] Establishing the origin of metastatic deposits in the setting of multiple primary malignancies: The role of massively parallel sequencing
    De Mattos-Arruda, Leticia
    Bidard, Francois-Clement
    Won, Helen H.
    Cortes, Javier
    Ng, Charlotte K. Y.
    Peg, Vicente
    Nuciforo, Paolo
    Jungbluth, Achim A.
    Weigelt, Britta
    Berger, Michael F.
    Seoane, Joan
    Reis-Filho, Jorge S.
    [J]. MOLECULAR ONCOLOGY, 2014, 8 (01) : 150 - 158
  • [6] FAGUET GB, 1990, BLOOD, V75, P1853
  • [7] NUDE A NEW HAIRLESS GENE WITH PLEIOTROPIC EFFECTS IN MOUSE
    FLANAGAN, SP
    [J]. GENETICAL RESEARCH, 1966, 8 (03) : 295 - &
  • [8] INTRATHYMIC ISLET CELL TRANSPLANTATION REDUCES BETA-CELL AUTOIMMUNITY AND PREVENTS DIABETES IN NOD/LT MICE
    GERLING, IC
    SERREZE, DV
    CHRISTIANSON, SW
    LEITER, EH
    [J]. DIABETES, 1992, 41 (12) : 1672 - 1676
  • [9] Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector
    Hiraoka, Kei
    Kimura, Takahiro
    Logg, Christopher R.
    Kasahara, Noriyuki
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (23) : 7108 - 7116
  • [10] Hotta Y, 2017, ONCOLYTIC VIROTHER, V6, P31, DOI 10.2147/OV.S127179